Appointed: June 16, 2010
Committee Chairmanship: Science & Technology Committee
Committee membership: Nomination & Governance Committee
Skills & experience: David brings to the Board his clinical medical experience in internal medicine, hematology-oncology and medical genetics, as well as his extensive basic biomedical laboratory research expertise. David will retire from the Board with effect from the conclusion of the 2018 Annual General Meeting. David obtained his BA at Yale University, MD at Duke University and completed his medical and research training at Harvard Medical School.
Key appointments: University of Michigan (James V. Neel Distinguished University Professor of Internal Medicine, Human Genetics and Pediatrics) and Howard Hughes Medical Institute (Investigator).